Market Tracker

07/29 6:05pm ET

Valeant Pharmaceuticals International Inc (NYSE:VRX)

During the Trading Day
123.70 +0.17 / +0.14%
Data as of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
123.69 -0.011 / -0.01%
 
Volume: 500.00

Today’s Trading

Previous close123.53
Today’s open124.16
Day’s range122.74 - 124.31
Volume1,250,324
Average volume (3 months)3,089,650
Market cap$41.2B
Dividend yield--
Data as of 4:00pm ET, 07/29/2014

Growth & Valuation

Earnings growth (last year)-610.53%
Earnings growth (this year)+39.15%
Earnings growth (next 5 years)+34.80%
Revenue growth (last year)+62.68%
P/E ratio--
Price/Sales6.53
Price/Book8.04

Competitors

 Today’s
change
Today’s
% change
SHPGShire PLC-1.01-0.40%
ALXNAlexion Pharmaceutic...+1.04+0.64%
AGNAllergan Inc+0.75+0.44%
ACTActavis PLC-0.09-0.04%
Data as of 4:04pm ET, 07/29/2014

Financials

Next reporting dateJuly 31, 2014
EPS forecast (this quarter)$1.91
Annual revenue (last year)$5.8B
Annual profit (last year)-$866.1M
Net profit margin-15.01%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts